...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Not adding up!

"Those who buy in on unsubstantiated internet rumours of a buyout may be left frustrated."

i see, so does it feel less frustrating & taste more like koolaid for you & others when it comes from the horses mouth?

get the feeling a couple posters here are in bed with buffet boy.

Share
New Message
Please login to post a reply